Speaking in general about the States, which is the closest to us and we're the most involved with them, I know that Horizon pharmaceuticals owns the patent for the new drug Procysbi. It has a seven year...and now they've added another three-year extension. Basically, for the next 10 years the price will continue to go up.
I can't speak to that in Canada because I think once the price is set, it's set. In the States, they will continue to increase it to make a profit, which these companies are known for—the rare disease market. It's a niche market when you have 2,000 patients, or in Canada you have 75 to 100 patients. You need their drug. It's a product that our kids couldn't live without.
I would really like to hear Horizon pharmaceuticals answer the question of why it's so expensive and what they can do to reduce the cost. Logistically, it's not a drug that should cost a lot of money to make.